Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 50268-875

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 50268-875). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

50 (873 15)

50 (873 15)
This text describes a medication identified as Venlafaxine Hydrochloride Extended-Release Capsules USP in a 37.5 mg strength. The medication is provided in a package containing 50 capsules. It is a prescription-only drug and should be stored at a temperature range of 20 to 25 degrees Celsius. The medication is manufactured by AVKARE in Pulaski, TN 38478. It includes usage instructions and information on handling.*
FDA Label Image

50 (874 15)

50 (874 15)
This text provides information about Venlafaxine Hydrochloride Extended-Release Capsules USP in 75 mg dosage form. The capsules are intended for prescription use, with 50 tablets in a unit dose packaging. The text also includes storage instructions, dosage details, and manufacturing information for the product by AVKARE located in Pulaski, TN.*
FDA Label Image

50 (875 15)

50 (875 15)
This text is a label for Venlafaxine Hydrochloride Extended-Release Capsules USP, with a strength of 150 mg. The medication is available in unit doses of 50 tablets (5 x 10). The label includes important information like the National Drug Code (NDC), dosage instructions, and the prescription status (Rx Only). It is essential to refer to the accompanying prescribing information for proper dosage details and guidelines.*
FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
This text appears to be a data sheet or document related to drug interactions and analysis. It mentions the drug Cimetidine, Imipramine, and an analyte called Venlafaxine. There is also a discussion about fold change and confidence intervals. The content seems to be related to pharmacokinetics and the effects of these drugs on certain parameters.*
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
This is a list of drugs and their interactions with ethanol, along with the corresponding analytes and pharmacokinetic (PK) parameters such as Cmax and AUC. The text also mentions fold change and 90% confidence intervals, providing valuable information for evaluating the effects of these drugs when combined with ethanol.*
FDA Label Image

Venlafaxinestructure (Venlafaxinestructure)

Venlafaxinestructure (Venlafaxinestructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.